May 19, 2017 20:48 pm UTC| Business
NEW YORK, May 19, 2017 -- Wolf Haldenstein Adler Freeman Herz LLP announces that a class action lawsuit has been filed against Neurotrope, Inc.("Neurotrope" or the "Company") (NASDAQ:NTRP) in the United States District...
May 19, 2017 20:48 pm UTC| Business
NEW YORK, May 19, 2017 -- Wolf Haldenstein Adler Freeman Herz LLP announces that a class action lawsuit has been filed against Neurotrope, Inc.("Neurotrope" or the "Company") (NASDAQ:NTRP) in the United States District...
Security Bancorp, Inc. Announces Annual Cash Dividend
May 19, 2017 20:44 pm UTC| Business
MCMINNVILLE, Tenn., May 19, 2017 -- Security Bancorp, Inc. (OTCBB:SCYT) announced that the Corporation’s Board of Directors has declared an annual cash dividend of $1.00 per share on the Corporation’s outstanding common...
Security Bancorp, Inc. Announces Annual Cash Dividend
May 19, 2017 20:44 pm UTC| Business
MCMINNVILLE, Tenn., May 19, 2017 -- Security Bancorp, Inc. (OTCBB:SCYT) announced that the Corporation’s Board of Directors has declared an annual cash dividend of $1.00 per share on the Corporation’s outstanding common...
GeneriCo, LLC Prevails in Inter Partes Review of United States Patent 8,865,688
May 19, 2017 20:36 pm UTC| Business
ST. LOUIS, May 19, 2017 -- GeneriCo, LLC (GeneriCo), a global specialty generic drug company, today announced that the Patent Trial and Appeal Board (“PTAB”) of the U.S. Patent and Trademark Office ruled in favor of its...
GeneriCo, LLC Prevails in Inter Partes Review of United States Patent 8,865,688
May 19, 2017 20:36 pm UTC| Business
ST. LOUIS, May 19, 2017 -- GeneriCo, LLC (GeneriCo), a global specialty generic drug company, today announced that the Patent Trial and Appeal Board (“PTAB”) of the U.S. Patent and Trademark Office ruled in favor of its...
Esperion to Participate in Fireside Chat at the UBS Global Healthcare Conference
May 19, 2017 20:31 pm UTC| Business
Fireside Chat Webcast on Tuesday, May 23, 2017 at 9:00 a.m. Eastern Time ANN ARBOR, Mich., May 19, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and...